Advertisement

Liver Diseases pp 545-552 | Cite as

Transient Elastography in Chronic Liver Diseases

  • Gamal El-Sayed Shiha
  • Nasser Mousa
Chapter

Abstract

Liver fibrosis is a sign of progressive liver disease and is commonly an indication for treatment. The present standard for diagnosing liver fibrosis is biopsy. But, due to liver biopsy limitations (inter-observer variation amongst pathologists, fibrosis staging systems and sampling errors), there is an urgent need to estimate the liver fibrosis stages and inflammation grades away from liver biopsy by noninvasive maneuvers. Therefore, in medical filed, there are many efforts to find noninvasive markers for estimation of liver fibrosis stage and to monitor disease progression and also response to treatment. One amongst the foremost common is transient elastography (FibroScan). Transient elastography (TE) is a non-invasive tool with acceptable correctness and reproducibility that allows rapid and easy assessment of liver fibrosis in many liver diseases. The aim of this review is to analysis the present proof regarding the clinical applications of TE in major liver diseases.

Keywords

Transient elastography Liver fibrosis Noninvasive maneuvers 

References

  1. 1.
    Bruix J, Sherman M. Management of hepatocellular carcinoma. [J] Hepatology. 2005;42(5):1208–36.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449–57.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Jung KS, Kim SU. Clinical applications of transient elastography. Clin Mol Hepatol. 2012;18(2):163.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835–47.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–35.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Roulot D, Czernichow S, Le Clesiau H, Costes L, Vergnaud C, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008;48:606–13.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Kim U, Choi H, Han K, Kim K, Park Y, Kim DY, et al. What are ‘true normal’ liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 2010;30:268–74.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Colombo S, Belloli L, Zaccanelli M, Badia E, Jamoletti C, Buonocore M, et al. Normal liver stiffness and its determinants in healthy blood donors. Dig Liver Dis. 2011;43:231–6.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Das K, Sarkar R, Ahmed M, Mridha R, Mukherjee S, Dhali GK, et al. Normal liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Hepatology. 2012;55:584–93.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Boursier J, Konate A, Guilluy M, Gorea G, Sawadogo A, Quemener E, et al. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur J Gastroenterol Hepatol. 2008;20:693–701.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Wong GL. Transient elastography: kill two birds with one stone? World Hepatol. 2013;5:264–74.CrossRefGoogle Scholar
  14. 14.
    Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Lédinghen V. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–35.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK, Chan HL. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol. 2011;26:300–5.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    de Lédinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol. 2008;32:58–67.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    de Lédinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010;30:1043–8.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008;48:1718–23.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Trifan A, Sfarti C, Cojocariu C, et al. Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis. Hepat Mon. 2011;11(5):372–5.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47(2):380–4.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Fung J, Lai C, Chan C, et al. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am J Gastroenterol. 2010;105(5):1116–22.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14(5):360–9.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Pradhan F, Ladak F, Tracey J, Crotty P, Myers RP. Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. Ann Hepatol. 2013;12(1):100–7.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Colli A, Pozzoni P, Berzuini A, et al. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;257(3):872–8.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Hopper I, Kemp W, Porapakkham P, et al. Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography. Eur J Heart Fail. 2012;14(6):621–7.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Arena U, Platon M, Stasi C, et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology. 2013;58(1):65–72.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Kim KM, Choi WB, Park SH, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382–8.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Shiha G, Ibrahim A, Helmy A, Sarin S, Omata M, Kumar A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1–30.CrossRefGoogle Scholar
  29. 29.
    Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41(1):48–54.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343–50.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Petta S, DiMarco V, Cammà C, Butera G, Cabibi D, Craxì A. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. AlimentPharmacol Ther. 2011;33:1350–60.Google Scholar
  32. 32.
    Rajakannu M, Coilly A, Adam R, Samuel D, Vibert E. Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation. J Hepatol. 2018;68(1):199–200.CrossRefGoogle Scholar
  33. 33.
    Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960–74.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Elsharkawy A, Alboraie M, Fouad R, Asem N, Abdo M, Elmakhzangy H, et al. Establishing ultrasound based transient elastography cutoffs for different stages of hepatic fibrosis and cirrhosis in Egyptian chronic hepatitis C patients. Arab J Gastroenterol. 2017;18(4):210–5.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Rout G, Nayak B, Patel AH, Gunjan D, Singh V, Kedia S. Therapy with oral directly acting agents in hepatitis C infection is associated with reduction in fibrosis and increase in hepatic steatosis on transient elastography. J Clin Exp Hepatol. 2019;9(2):207–14.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12(12):1791–8.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Mauro E, Crespo G, Montironi C, Londoño MC, Hernández-Gea V, Ruiz P, et al. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C. Hepatology. 2018;67(5):1683–94.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Erman A, Sathya A, Nam A, Bielecki J, Feld J, Thein HH, et al. Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: a systematic review and meta-analysis. J Viral Hepat. 2018;25(5):502–13.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Awad M-D, Shiha GE, Sallam FA, Mohamed A, El Tawab A. Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis C. J Egypt Soc Parasitol. 2013;43:805–19.CrossRefGoogle Scholar
  41. 41.
    Qi X, Liu F, Li Z, et al. Insufficient accuracy of computed tomography-based portal pressure assessment in hepatitis B virus-related cirrhosis: an analysis of data from CHESS-1601 trial. J Hepatol. 2017;68(1):210–1.CrossRefGoogle Scholar
  42. 42.
    Qi X, An M, Wu T, Jiang D, Peng M, Wang W, et al. Transient elastography for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Can J Gastroenterol Hepatol. 2018;2018:3406789, 13 pages.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Verveer C, Zondervan PE, ten Kate FJ, Hansen BE, Janssen HL, de Knegt RJ. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 2012;32(4):622–8.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012;32(4):612–21.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Kitahara S, et al. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol. 2011;46(11):1324–34.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012;56(3):696–703.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27:1261–8.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Castera L, Le Bail B, Roudot-Thoraval F, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol. 2009;50:59–68.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67(2):399–411.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Li Y, Cai Q, Zhang Y, et al. Development of algorithms based on serum markers and transient elastography for detecting significant fibrosis and cirrhosis in chronic hepatitis B patients: significant reduction in liver biopsy. Hepatol Res. 2016;46:1367–79.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Xu Q, Sheng L, Bao H, et al. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2017;32:639–44.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Transient elastography (FibroScan) performs better than non-invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients. Med Sci Monit. 2017;23:5106–12.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Hashemi S, Alavian S, Fesharaki M. Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Caspian J Intern Med. 2016;7(4):242–52.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Kwok R, Tse YK, Wong GH, Ha Y, Lee A, Ngu M, et al. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease–the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther. 2014;39(3):254–69.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Hardy T, McPherson S. Imaging-based assessment of steatosis, inflammation and fibrosis in NAFLD. Curr Hepatol Rep. 2017;16(4):298–307.CrossRefGoogle Scholar
  56. 56.
    Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617–49.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454–62.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Friedrich-Rust M, Hadji-Hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, Zeuzem S, Bojunga J. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol. 2010;20(10):2390–6.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Masuzaki R, Tateishi R, Yoshida H, et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009;49:1954–61.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Vergniol J, Foucher J, Terrebonne E, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140:1970–9.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Nacif L, Gomes C, Mischiatti M, Kim V, Paranaguá-Vezozzo D, Reinoso G, et al., editors. Transient elastography in acute cellular rejection following liver transplantation: systematic review. Transplantation Proceedings. Amsterdam: Elsevier; 2018.Google Scholar
  62. 62.
    Pavlov CS, Casazza G, Nikolova D, Tsochatzis E, Burroughs AK, Ivashkin VT, Gluud C. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev. 2015;1:CD010542.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Sasso M, Tengher-Barna I, Ziol M, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan: validation in chronic hepatitis C. J Viral Hepat. 2012;19:244–53.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    de Ledinghen V, Wong VW, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan (R). J Hepatol. 2012;56:833–9.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Kumar M, Rastogi A, Singh T, Behari C, Gupta E, Garg H, Kumar R, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol. 2013;28:1194–201.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, Ahn SH, Chon CY, Lee HW, Park Y, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int. 2014;34:102–9.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Caussy C, Alquiraish M, Nguyen P, Hernandez C, Cepin S, Fortney L. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018;67:1348–59.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Wong JS, Wong GL, Chan AW, et al. Liver stiffness measurement by transient elastography as a predictor on post-hepatectomy outcomes. Ann Surg. 2013;257(5):922–8.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Jung KS, Kim SU, Choi GH, et al. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan). Ann Surg Oncol. 2012;19:4278–86.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Gamal El-Sayed Shiha
    • 1
    • 2
  • Nasser Mousa
    • 3
  1. 1.Department of Internal MedicineMansoura UniversityMansouraEgypt
  2. 2.Egyptian Liver Research Institute and Hospital (ELRIH)SherbinEgypt
  3. 3.Department of Tropical MedicineMansoura UniversityMansouraEgypt

Personalised recommendations